Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Eyelid Neoplasms | 10 | 2017 | 94 | 2.730 |
Why?
|
Eye Neoplasms | 7 | 2022 | 313 | 2.300 |
Why?
|
Eyelid Diseases | 7 | 2023 | 155 | 2.210 |
Why?
|
Adenocarcinoma, Sebaceous | 5 | 2022 | 21 | 2.020 |
Why?
|
Orbital Neoplasms | 7 | 2023 | 225 | 1.850 |
Why?
|
Granuloma, Foreign-Body | 3 | 2022 | 45 | 1.790 |
Why?
|
Sebaceous Gland Neoplasms | 5 | 2022 | 39 | 1.590 |
Why?
|
Mucopolysaccharidosis I | 2 | 2021 | 50 | 1.560 |
Why?
|
Exophthalmos | 2 | 2023 | 97 | 1.490 |
Why?
|
Conjunctival Neoplasms | 8 | 2022 | 79 | 1.420 |
Why?
|
Eyelids | 8 | 2023 | 265 | 1.390 |
Why?
|
Eye | 3 | 2022 | 729 | 1.370 |
Why?
|
Eye Diseases | 3 | 2023 | 669 | 1.270 |
Why?
|
Orbit | 6 | 2023 | 426 | 1.150 |
Why?
|
Corneal Diseases | 4 | 2021 | 636 | 1.140 |
Why?
|
Conjunctival Diseases | 4 | 2021 | 122 | 1.130 |
Why?
|
Neuroectodermal Tumors, Primitive | 6 | 2016 | 140 | 1.120 |
Why?
|
Lacrimal Apparatus Diseases | 5 | 2022 | 65 | 1.080 |
Why?
|
Sweat Gland Neoplasms | 3 | 2022 | 108 | 1.030 |
Why?
|
Conjunctiva | 9 | 2022 | 494 | 1.010 |
Why?
|
Skin Neoplasms | 11 | 2023 | 5686 | 0.950 |
Why?
|
Glomus Tumor | 1 | 2023 | 66 | 0.890 |
Why?
|
Syringoma | 1 | 2022 | 5 | 0.890 |
Why?
|
Angioedema | 1 | 2023 | 187 | 0.810 |
Why?
|
Silicones | 1 | 2022 | 250 | 0.800 |
Why?
|
Cysts | 6 | 2017 | 678 | 0.740 |
Why?
|
Edema | 1 | 2023 | 789 | 0.670 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 2 | 2022 | 180 | 0.660 |
Why?
|
Lacrimal Apparatus | 5 | 2021 | 225 | 0.650 |
Why?
|
Skull Neoplasms | 1 | 2019 | 173 | 0.640 |
Why?
|
Pathology | 1 | 2021 | 272 | 0.640 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2019 | 116 | 0.630 |
Why?
|
Facial Bones | 1 | 2019 | 201 | 0.630 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2021 | 280 | 0.610 |
Why?
|
Diplopia | 1 | 2018 | 200 | 0.600 |
Why?
|
RANK Ligand | 1 | 2019 | 326 | 0.600 |
Why?
|
Corneal Transplantation | 1 | 2021 | 386 | 0.580 |
Why?
|
Granuloma, Pyogenic | 1 | 2016 | 48 | 0.540 |
Why?
|
Keratosis, Seborrheic | 1 | 2015 | 27 | 0.530 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 2043 | 0.530 |
Why?
|
Vision Disorders | 1 | 2022 | 1058 | 0.520 |
Why?
|
Neurofibroma | 1 | 2016 | 106 | 0.520 |
Why?
|
Papilloma, Inverted | 1 | 2014 | 16 | 0.510 |
Why?
|
In Situ Hybridization | 1 | 2019 | 1950 | 0.510 |
Why?
|
Sarcoma, Synovial | 1 | 2016 | 167 | 0.510 |
Why?
|
Headache | 1 | 2022 | 1226 | 0.500 |
Why?
|
Lymphoma | 1 | 2024 | 1877 | 0.500 |
Why?
|
Uveal Neoplasms | 4 | 2022 | 310 | 0.490 |
Why?
|
Neuroma | 1 | 2016 | 103 | 0.490 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 705 | 0.470 |
Why?
|
Orbital Diseases | 4 | 2017 | 181 | 0.470 |
Why?
|
Nasolacrimal Duct | 3 | 2022 | 74 | 0.470 |
Why?
|
Retinoblastoma | 1 | 2016 | 318 | 0.450 |
Why?
|
Diagnosis, Differential | 14 | 2022 | 12959 | 0.430 |
Why?
|
Molecular Biology | 1 | 2016 | 596 | 0.430 |
Why?
|
Melanoma | 5 | 2023 | 5510 | 0.420 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2133 | 0.410 |
Why?
|
Skin Diseases | 2 | 2021 | 1065 | 0.410 |
Why?
|
Papillomavirus Infections | 3 | 2021 | 1587 | 0.390 |
Why?
|
Dermatology | 1 | 2021 | 872 | 0.390 |
Why?
|
Hyperpigmentation | 2 | 2022 | 112 | 0.380 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1622 | 0.380 |
Why?
|
Immunohistochemistry | 12 | 2021 | 11366 | 0.380 |
Why?
|
Ciliary Body | 3 | 2016 | 173 | 0.370 |
Why?
|
Neurilemmoma | 1 | 2016 | 547 | 0.360 |
Why?
|
Biopsy | 13 | 2018 | 6756 | 0.350 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2021 | 4034 | 0.340 |
Why?
|
Melanosis | 2 | 2022 | 78 | 0.330 |
Why?
|
Dacryocystitis | 2 | 2022 | 70 | 0.330 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2016 | 1581 | 0.320 |
Why?
|
Humans | 84 | 2024 | 744343 | 0.320 |
Why?
|
Eosinophilia | 2 | 2023 | 541 | 0.320 |
Why?
|
Cornea | 3 | 2021 | 1524 | 0.300 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2529 | 0.290 |
Why?
|
Retrospective Studies | 24 | 2023 | 77449 | 0.290 |
Why?
|
Ophthalmologic Surgical Procedures | 4 | 2017 | 349 | 0.280 |
Why?
|
Immunoenzyme Techniques | 5 | 2015 | 1799 | 0.280 |
Why?
|
Eye Burns | 2 | 2017 | 103 | 0.270 |
Why?
|
Hair Diseases | 2 | 2016 | 74 | 0.270 |
Why?
|
Burns, Chemical | 2 | 2017 | 159 | 0.260 |
Why?
|
Epidermal Cyst | 2 | 2016 | 62 | 0.260 |
Why?
|
Glucose Transporter Type 1 | 2 | 2016 | 192 | 0.260 |
Why?
|
Keratin-14 | 2 | 2014 | 57 | 0.250 |
Why?
|
Human papillomavirus 16 | 2 | 2017 | 262 | 0.250 |
Why?
|
Retinal Neoplasms | 2 | 2016 | 144 | 0.240 |
Why?
|
Choristoma | 2 | 2016 | 213 | 0.240 |
Why?
|
Antigens, CD34 | 2 | 2016 | 657 | 0.230 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5751 | 0.230 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2021 | 2942 | 0.220 |
Why?
|
Oculomotor Muscles | 2 | 2017 | 371 | 0.220 |
Why?
|
Keratin-17 | 3 | 2022 | 26 | 0.220 |
Why?
|
Female | 43 | 2023 | 380194 | 0.210 |
Why?
|
Optic Atrophy | 1 | 2023 | 79 | 0.210 |
Why?
|
Prostheses and Implants | 2 | 2022 | 1387 | 0.210 |
Why?
|
Cartilage | 2 | 2016 | 818 | 0.210 |
Why?
|
Middle Aged | 33 | 2023 | 213383 | 0.200 |
Why?
|
Lacrimal Duct Obstruction | 1 | 2022 | 48 | 0.200 |
Why?
|
Minocycline | 1 | 2022 | 163 | 0.200 |
Why?
|
Color | 1 | 2022 | 307 | 0.200 |
Why?
|
Wet Macular Degeneration | 1 | 2023 | 145 | 0.200 |
Why?
|
Erythema | 1 | 2022 | 257 | 0.200 |
Why?
|
Dacryocystorhinostomy | 1 | 2022 | 72 | 0.190 |
Why?
|
Papilloma | 1 | 2021 | 148 | 0.190 |
Why?
|
Male | 38 | 2023 | 350118 | 0.190 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8428 | 0.180 |
Why?
|
Nevus | 1 | 2022 | 204 | 0.180 |
Why?
|
Retinal Diseases | 2 | 2017 | 683 | 0.180 |
Why?
|
Choroidal Neovascularization | 1 | 2023 | 343 | 0.180 |
Why?
|
Keratins | 3 | 2016 | 515 | 0.180 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 2015 | 501 | 0.180 |
Why?
|
Nose Neoplasms | 1 | 2021 | 246 | 0.170 |
Why?
|
Adult | 23 | 2023 | 214055 | 0.170 |
Why?
|
Strabismus | 1 | 2023 | 287 | 0.170 |
Why?
|
Craniosynostoses | 1 | 2023 | 401 | 0.160 |
Why?
|
Keratin-7 | 2 | 2016 | 57 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 221 | 0.160 |
Why?
|
Hidrocystoma | 1 | 2017 | 11 | 0.150 |
Why?
|
Anophthalmos | 1 | 2017 | 22 | 0.150 |
Why?
|
Apocrine Glands | 1 | 2017 | 31 | 0.150 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 294 | 0.150 |
Why?
|
Ectropion | 1 | 2017 | 26 | 0.150 |
Why?
|
Eccrine Glands | 1 | 2017 | 45 | 0.150 |
Why?
|
Silicone Oils | 1 | 2016 | 22 | 0.150 |
Why?
|
Carcinoma, Basal Cell | 1 | 2022 | 545 | 0.140 |
Why?
|
Pilomatrixoma | 1 | 2016 | 23 | 0.140 |
Why?
|
Endotamponade | 1 | 2016 | 35 | 0.140 |
Why?
|
Eyebrows | 1 | 2016 | 28 | 0.140 |
Why?
|
Retinal Vasculitis | 1 | 2016 | 42 | 0.140 |
Why?
|
Blepharitis | 1 | 2016 | 36 | 0.140 |
Why?
|
Mucorales | 1 | 2016 | 33 | 0.140 |
Why?
|
Anterior Capsule of the Lens | 1 | 2015 | 3 | 0.140 |
Why?
|
Blepharoplasty | 1 | 2016 | 50 | 0.140 |
Why?
|
Epiretinal Membrane | 1 | 2016 | 68 | 0.140 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 2016 | 36 | 0.140 |
Why?
|
Orbital Myositis | 1 | 2016 | 20 | 0.140 |
Why?
|
Glucocorticoids | 4 | 2018 | 2107 | 0.140 |
Why?
|
Pigmentation | 1 | 2016 | 148 | 0.140 |
Why?
|
Myofibromatosis | 1 | 2016 | 30 | 0.140 |
Why?
|
HMGA2 Protein | 1 | 2016 | 123 | 0.140 |
Why?
|
Orbital Pseudotumor | 1 | 2016 | 42 | 0.140 |
Why?
|
Goldenhar Syndrome | 1 | 2016 | 37 | 0.130 |
Why?
|
Adenoma, Pleomorphic | 1 | 2016 | 75 | 0.130 |
Why?
|
Macular Degeneration | 1 | 2023 | 980 | 0.130 |
Why?
|
Eye Infections, Viral | 1 | 2016 | 57 | 0.130 |
Why?
|
Ki-67 Antigen | 2 | 2015 | 644 | 0.130 |
Why?
|
Myofibroma | 1 | 2016 | 50 | 0.130 |
Why?
|
Iris Diseases | 1 | 2015 | 40 | 0.130 |
Why?
|
Human papillomavirus 18 | 1 | 2016 | 128 | 0.130 |
Why?
|
Retinoscopy | 1 | 2015 | 27 | 0.130 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2016 | 768 | 0.130 |
Why?
|
Histiocytes | 1 | 2015 | 103 | 0.130 |
Why?
|
Mucormycosis | 1 | 2016 | 97 | 0.130 |
Why?
|
Scotoma | 1 | 2016 | 139 | 0.130 |
Why?
|
S100 Proteins | 1 | 2016 | 259 | 0.130 |
Why?
|
Skin Ulcer | 1 | 2016 | 120 | 0.130 |
Why?
|
Eye Infections, Fungal | 1 | 2016 | 110 | 0.130 |
Why?
|
Maxillary Sinus Neoplasms | 1 | 2015 | 40 | 0.130 |
Why?
|
Corneal Neovascularization | 1 | 2017 | 188 | 0.130 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2016 | 111 | 0.130 |
Why?
|
Gliosis | 1 | 2015 | 245 | 0.130 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 2015 | 67 | 0.120 |
Why?
|
Granuloma | 1 | 2017 | 319 | 0.120 |
Why?
|
Brain | 1 | 2021 | 26385 | 0.120 |
Why?
|
Papillomaviridae | 2 | 2021 | 1119 | 0.120 |
Why?
|
Retinal Hemorrhage | 1 | 2015 | 96 | 0.120 |
Why?
|
Dermis | 1 | 2016 | 207 | 0.120 |
Why?
|
Mouth Mucosa | 1 | 2017 | 434 | 0.120 |
Why?
|
Myxoma | 1 | 2014 | 130 | 0.120 |
Why?
|
Hair Follicle | 1 | 2016 | 209 | 0.120 |
Why?
|
Rupture, Spontaneous | 1 | 2014 | 354 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 8 | 2017 | 20129 | 0.120 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2015 | 367 | 0.120 |
Why?
|
Pituitary Gland | 1 | 2016 | 665 | 0.110 |
Why?
|
Choroid Neoplasms | 1 | 2014 | 175 | 0.110 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2015 | 171 | 0.110 |
Why?
|
Retinal Pigment Epithelium | 1 | 2016 | 302 | 0.110 |
Why?
|
Myotonic Dystrophy | 1 | 2014 | 78 | 0.110 |
Why?
|
Rhabdomyosarcoma | 1 | 2016 | 382 | 0.110 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2016 | 233 | 0.110 |
Why?
|
Aged | 15 | 2023 | 163280 | 0.110 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2016 | 693 | 0.110 |
Why?
|
Rhabdoid Tumor | 1 | 2014 | 212 | 0.110 |
Why?
|
Pathology, Molecular | 1 | 2016 | 326 | 0.110 |
Why?
|
Giant Cell Arteritis | 1 | 2016 | 292 | 0.110 |
Why?
|
Carcinoma, Lobular | 1 | 2017 | 484 | 0.110 |
Why?
|
Retinal Detachment | 1 | 2016 | 411 | 0.110 |
Why?
|
Respiratory Mucosa | 1 | 2016 | 427 | 0.110 |
Why?
|
Fuchs' Endothelial Dystrophy | 1 | 2014 | 84 | 0.100 |
Why?
|
Pregnancy Complications | 2 | 2016 | 2861 | 0.100 |
Why?
|
Prosthesis Implantation | 1 | 2017 | 642 | 0.100 |
Why?
|
Immunoglobulin G | 1 | 2024 | 4560 | 0.100 |
Why?
|
Inflammation | 2 | 2024 | 10638 | 0.100 |
Why?
|
Adolescent | 10 | 2019 | 85781 | 0.100 |
Why?
|
Actins | 2 | 2016 | 2121 | 0.100 |
Why?
|
Mucin-1 | 1 | 2016 | 543 | 0.100 |
Why?
|
Aged, 80 and over | 7 | 2017 | 57776 | 0.100 |
Why?
|
Young Adult | 8 | 2019 | 56430 | 0.100 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2015 | 332 | 0.100 |
Why?
|
Immunity, Cellular | 1 | 2017 | 1607 | 0.100 |
Why?
|
Immunocompromised Host | 1 | 2016 | 847 | 0.100 |
Why?
|
Retinal Vessels | 1 | 2015 | 772 | 0.090 |
Why?
|
Vascular Malformations | 1 | 2015 | 454 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2017 | 1101 | 0.090 |
Why?
|
DNA, Viral | 1 | 2016 | 2225 | 0.090 |
Why?
|
Visual Fields | 1 | 2016 | 1047 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 10 | 2018 | 35421 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17446 | 0.080 |
Why?
|
Antigens, CD | 1 | 2018 | 4026 | 0.080 |
Why?
|
Child, Preschool | 7 | 2019 | 41006 | 0.080 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3616 | 0.080 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2017 | 1378 | 0.070 |
Why?
|
Child | 6 | 2022 | 77709 | 0.070 |
Why?
|
Infant | 6 | 2019 | 35136 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 895 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6171 | 0.070 |
Why?
|
Neoplasm Proteins | 5 | 2016 | 3703 | 0.070 |
Why?
|
Child Abuse | 1 | 2015 | 1030 | 0.070 |
Why?
|
Antibodies, Viral | 1 | 2017 | 3176 | 0.070 |
Why?
|
B-Lymphocytes | 2 | 2017 | 4665 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1903 | 0.070 |
Why?
|
Eye Enucleation | 2 | 2016 | 128 | 0.070 |
Why?
|
Disease Management | 1 | 2016 | 2459 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 2948 | 0.060 |
Why?
|
Limbus Corneae | 2 | 2016 | 144 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14722 | 0.060 |
Why?
|
Ileum | 1 | 2005 | 565 | 0.060 |
Why?
|
Brain Injuries | 1 | 2015 | 2025 | 0.050 |
Why?
|
Visual Acuity | 3 | 2016 | 2530 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2017 | 11031 | 0.050 |
Why?
|
Melanocytes | 2 | 2016 | 515 | 0.050 |
Why?
|
Intravitreal Injections | 1 | 2023 | 344 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12261 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16365 | 0.050 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2005 | 341 | 0.050 |
Why?
|
T-Lymphocytes | 2 | 2017 | 10180 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8388 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2016 | 13033 | 0.050 |
Why?
|
Follow-Up Studies | 6 | 2017 | 39050 | 0.050 |
Why?
|
Endothelial Growth Factors | 1 | 2023 | 694 | 0.050 |
Why?
|
Cellulitis | 1 | 2022 | 206 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2017 | 4420 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2017 | 20822 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9648 | 0.040 |
Why?
|
Alopecia | 1 | 2023 | 382 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3752 | 0.040 |
Why?
|
Hyperplasia | 1 | 2022 | 1185 | 0.040 |
Why?
|
Siblings | 1 | 2023 | 854 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9239 | 0.040 |
Why?
|
Growth Disorders | 1 | 2023 | 645 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2017 | 15295 | 0.040 |
Why?
|
Emulsions | 1 | 2016 | 156 | 0.040 |
Why?
|
Fibrosis | 1 | 2023 | 2029 | 0.030 |
Why?
|
Antigens, CD20 | 1 | 2017 | 199 | 0.030 |
Why?
|
Drug Implants | 1 | 2017 | 244 | 0.030 |
Why?
|
Keratin-18 | 1 | 2016 | 39 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2017 | 4851 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13695 | 0.030 |
Why?
|
Microscopy, Acoustic | 1 | 2015 | 45 | 0.030 |
Why?
|
Curettage | 1 | 2015 | 73 | 0.030 |
Why?
|
Acyclovir | 1 | 2016 | 272 | 0.030 |
Why?
|
Triamcinolone | 1 | 2015 | 68 | 0.030 |
Why?
|
Herpesvirus 3, Human | 1 | 2016 | 204 | 0.030 |
Why?
|
Vitreous Body | 1 | 2016 | 389 | 0.030 |
Why?
|
Injections, Intralesional | 1 | 2015 | 276 | 0.030 |
Why?
|
Valine | 1 | 2016 | 413 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2015 | 528 | 0.030 |
Why?
|
Visual Field Tests | 1 | 2016 | 383 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2022 | 7181 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2022 | 1988 | 0.030 |
Why?
|
Risk Factors | 1 | 2021 | 72290 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 63114 | 0.030 |
Why?
|
Pregnancy Trimester, Third | 1 | 2016 | 571 | 0.030 |
Why?
|
Tomography, Optical Coherence | 2 | 2016 | 2657 | 0.030 |
Why?
|
Debridement | 1 | 2016 | 492 | 0.030 |
Why?
|
Vitrectomy | 1 | 2016 | 365 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2023 | 2038 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2017 | 968 | 0.030 |
Why?
|
Ultrasonography | 2 | 2015 | 5985 | 0.030 |
Why?
|
Goblet Cells | 1 | 2015 | 287 | 0.030 |
Why?
|
Incidental Findings | 1 | 2017 | 689 | 0.030 |
Why?
|
Antifungal Agents | 1 | 2016 | 730 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2016 | 1641 | 0.020 |
Why?
|
Epigenomics | 1 | 2016 | 903 | 0.020 |
Why?
|
Gene Dosage | 1 | 2015 | 1252 | 0.020 |
Why?
|
Morbidity | 1 | 2016 | 1769 | 0.020 |
Why?
|
Gene Amplification | 1 | 2015 | 1063 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2015 | 1100 | 0.020 |
Why?
|
Rabbits | 1 | 2017 | 4894 | 0.020 |
Why?
|
Neuroglia | 1 | 2015 | 927 | 0.020 |
Why?
|
Liver | 1 | 2005 | 7474 | 0.020 |
Why?
|
Skin | 1 | 2022 | 4364 | 0.020 |
Why?
|
Observer Variation | 1 | 2015 | 2593 | 0.020 |
Why?
|
Receptors, Androgen | 1 | 2015 | 1058 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2015 | 2649 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2005 | 9274 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 3913 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2015 | 2715 | 0.020 |
Why?
|
Antirheumatic Agents | 1 | 2017 | 1339 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3920 | 0.020 |
Why?
|
Retina | 1 | 2017 | 2616 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2016 | 25625 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5974 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8642 | 0.020 |
Why?
|
Pregnancy | 2 | 2016 | 29144 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2016 | 2987 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18029 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2005 | 2726 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2016 | 11483 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2015 | 7880 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 19905 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2005 | 8301 | 0.010 |
Why?
|
Cytokines | 1 | 2005 | 7322 | 0.010 |
Why?
|
Animals | 2 | 2017 | 168757 | 0.010 |
Why?
|
Rats | 1 | 2005 | 24260 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2005 | 15540 | 0.000 |
Why?
|